PRNewsWire
11 Aug 2026, 10:45 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Cardinal Health's non-GAAP diluted EPS for fiscal year 2026 increased 37% to $11.26. — Significant bottom-line growth over a full fiscal year typically drives positive investor sentiment and valuation expansion.
+0.60Fiscal year 2026 revenues increased 14% to $254.2 billion, with all five operating segments achieving double-digit profit growth. — Broad-based growth across all business units suggests strong operational health and scalable execution of the company's strategy.
+0.50Fourth quarter GAAP operating earnings surged 70% to $729 million. — A sharp quarterly increase in operating earnings demonstrates strong short-term momentum heading into the next fiscal year.
+0.40Continue reading
6 related stories
Top 3 movers · tap to explore
Non-GAAP earnings included a one-time $100 million positive impact from IEEPA tariff refunds in the GMPD segment. — One-time gains inflate current earnings and must be stripped out to understand the sustainable organic growth rate.
Which stocks this story touches
The company reported strong fiscal year 2026 results with significant increases in revenue, operating earnings, and non-GAAP diluted EPS.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Barrons
1h ago
